Request Sample Inquiry
Nuclear Medicine Market

Nuclear Medicine Market

Nuclear Medicine Market - Global Industry Assessment & Forecast

img
Healthcare
Number Of Pages # Pages:

145

Base Year:

2022

Date

Sep - 2024

Format:

PDF XLS PPT

Report Code:

VMR-1847

Segments Covered
  • By Type By Type Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine, Brachytherapy Isotopes
  • By Applications By Applications Diagnostic Applications, Procedural Volume Assessment, Diagnostic Procedures, Therapeutic Procedures
  • By Procedural Volume Assessment By Procedural Volume Assessment Diagnostic Procedures, Therapeutic Procedures
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 7.88 Billion
Revenue 2030Revenue 2030: USD 20.37 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 12.60%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Nuclear Medicine Market - Segment Analysis
    1. Overview
    2. Global Nuclear Medicine Market, 2016 - 2028 (USD Million)
    3. Global Nuclear Medicine Market - by Type
      1. By Diagnostic Nuclear Medicine
      2. By Therapeutic Nuclear Medicine
      3. By Brachytherapy Isotopes
    4. Global Nuclear Medicine Market - by Applications
      1. By Diagnostic Applications
      2. By Procedural Volume Assessment
      3. By Diagnostic Procedures
      4. By Therapeutic Procedures
    5. Global Nuclear Medicine Market - by Procedural Volume Assessment
      1. By Diagnostic Procedures
      2. By Therapeutic Procedures
    6. Global Nuclear Medicine Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    7. Market comparative analysis
  4. North America Nuclear Medicine Market - Segment Analysis
    1. Overview
    2. North America Nuclear Medicine Market, 2016 - 2028 (USD Million)
    3. North America Nuclear Medicine Market, by Type
      1. By Diagnostic Nuclear Medicine
      2. By Therapeutic Nuclear Medicine
      3. By Brachytherapy Isotopes
    4. North America Nuclear Medicine Market, by Applications
      1. By Diagnostic Applications
      2. By Procedural Volume Assessment
      3. By Diagnostic Procedures
      4. By Therapeutic Procedures
    5. North America Nuclear Medicine Market, by Procedural Volume Assessment
      1. By Diagnostic Procedures
      2. By Therapeutic Procedures
    6. North America Nuclear Medicine Market, by Country
      1. U.S.
        1. U.S. Nuclear Medicine Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By Therapeutic Nuclear Medicine
          3. By Brachytherapy Isotopes
        2. U.S. Nuclear Medicine Market, By Applications
          1. By Diagnostic Applications
          2. By Procedural Volume Assessment
          3. By Diagnostic Procedures
          4. By Therapeutic Procedures
        3. U.S. Nuclear Medicine Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
      2. Canada
        1. Canada Nuclear Medicine Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By Therapeutic Nuclear Medicine
          3. By Brachytherapy Isotopes
        2. Canada Nuclear Medicine Market, By Applications
          1. By Diagnostic Applications
          2. By Procedural Volume Assessment
          3. By Diagnostic Procedures
          4. By Therapeutic Procedures
        3. Canada Nuclear Medicine Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
      3. Mexico
        1. Mexico Nuclear Medicine Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By Therapeutic Nuclear Medicine
          3. By Brachytherapy Isotopes
        2. Mexico Nuclear Medicine Market, By Applications
          1. By Diagnostic Applications
          2. By Procedural Volume Assessment
          3. By Diagnostic Procedures
          4. By Therapeutic Procedures
        3. Mexico Nuclear Medicine Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
  5. Europe Nuclear Medicine Market - Segment Analysis
    1. Overview
    2. Europe Nuclear Medicine Market, 2016 - 2028 (USD Million)
    3. Europe Nuclear Medicine Market, by Type
      1. By Diagnostic Nuclear Medicine
      2. By Therapeutic Nuclear Medicine
      3. By Brachytherapy Isotopes
    4. Europe Nuclear Medicine Market, by Applications
      1. By Diagnostic Applications
      2. By Procedural Volume Assessment
      3. By Diagnostic Procedures
      4. By Therapeutic Procedures
    5. Europe Nuclear Medicine Market, by Procedural Volume Assessment
      1. By Diagnostic Procedures
      2. By Therapeutic Procedures
    6. Europe Nuclear Medicine Market, by Country
      1. Germany
        1. Germany Nuclear Medicine Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By Therapeutic Nuclear Medicine
          3. By Brachytherapy Isotopes
        2. Germany Nuclear Medicine Market, By Applications
          1. By Diagnostic Applications
          2. By Procedural Volume Assessment
          3. By Diagnostic Procedures
          4. By Therapeutic Procedures
        3. Germany Nuclear Medicine Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
      2. UK
        1. UK Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By Therapeutic Nuclear Medicine
          3. By Brachytherapy Isotopes
        2. UK Market, By Applications
          1. By Diagnostic Applications
          2. By Procedural Volume Assessment
          3. By Diagnostic Procedures
          4. By Therapeutic Procedures
        3. UK Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
      3. France
        1. France Nuclear Medicine Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By Therapeutic Nuclear Medicine
          3. By Brachytherapy Isotopes
        2. France Nuclear Medicine Market, By Applications
          1. By Diagnostic Applications
          2. By Procedural Volume Assessment
          3. By Diagnostic Procedures
          4. By Therapeutic Procedures
        3. France Nuclear Medicine Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
      4. Spain
        1. Spain Nuclear Medicine Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By Therapeutic Nuclear Medicine
          3. By Brachytherapy Isotopes
        2. Spain Nuclear Medicine Market, By Applications
          1. By Diagnostic Applications
          2. By Procedural Volume Assessment
          3. By Diagnostic Procedures
          4. By Therapeutic Procedures
        3. Spain Nuclear Medicine Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
      5. Italy
        1. Italy Nuclear Medicine Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By Therapeutic Nuclear Medicine
          3. By Brachytherapy Isotopes
        2. Italy Nuclear Medicine Market, By Applications
          1. By Diagnostic Applications
          2. By Procedural Volume Assessment
          3. By Diagnostic Procedures
          4. By Therapeutic Procedures
        3. Italy Nuclear Medicine Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
      6. BENELUX
        1. BENELUX Nuclear Medicine Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By Therapeutic Nuclear Medicine
          3. By Brachytherapy Isotopes
        2. BENELUX Nuclear Medicine Market, By Applications
          1. By Diagnostic Applications
          2. By Procedural Volume Assessment
          3. By Diagnostic Procedures
          4. By Therapeutic Procedures
        3. BENELUX Nuclear Medicine Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
      7. Rest of Europe
        1. Rest Of Europe Nuclear Medicine Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By Therapeutic Nuclear Medicine
          3. By Brachytherapy Isotopes
        2. Rest Of Europe Nuclear Medicine Market, By Applications
          1. By Diagnostic Applications
          2. By Procedural Volume Assessment
          3. By Diagnostic Procedures
          4. By Therapeutic Procedures
        3. Rest Of Europe Nuclear Medicine Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
  6. Asia Pacific Nuclear Medicine Market - Segment Analysis
    1. Overview
    2. Asia Pacific Nuclear Medicine Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Nuclear Medicine Market, by Type
      1. By Diagnostic Nuclear Medicine
      2. By Therapeutic Nuclear Medicine
      3. By Brachytherapy Isotopes
    4. Asia Pacific Nuclear Medicine Market, by Applications
      1. By Diagnostic Applications
      2. By Procedural Volume Assessment
      3. By Diagnostic Procedures
      4. By Therapeutic Procedures
    5. Asia Pacific Nuclear Medicine Market, by Procedural Volume Assessment
      1. By Diagnostic Procedures
      2. By Therapeutic Procedures
    6. Asia Pacific Nuclear Medicine Market, by Country
      1. China
        1. China Nuclear Medicine Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By Therapeutic Nuclear Medicine
          3. By Brachytherapy Isotopes
        2. China Nuclear Medicine Market, By Applications
          1. By Diagnostic Applications
          2. By Procedural Volume Assessment
          3. By Diagnostic Procedures
          4. By Therapeutic Procedures
        3. China Nuclear Medicine Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
      2. Japan
        1. Japan Nuclear Medicine Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By Therapeutic Nuclear Medicine
          3. By Brachytherapy Isotopes
        2. Japan Nuclear Medicine Market, By Applications
          1. By Diagnostic Applications
          2. By Procedural Volume Assessment
          3. By Diagnostic Procedures
          4. By Therapeutic Procedures
        3. Japan Nuclear Medicine Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
      3. India
        1. India Nuclear Medicine Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By Therapeutic Nuclear Medicine
          3. By Brachytherapy Isotopes
        2. India Nuclear Medicine Market, By Applications
          1. By Diagnostic Applications
          2. By Procedural Volume Assessment
          3. By Diagnostic Procedures
          4. By Therapeutic Procedures
        3. India Nuclear Medicine Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
      4. South Korea
        1. South Korea Nuclear Medicine Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By Therapeutic Nuclear Medicine
          3. By Brachytherapy Isotopes
        2. South Korea Nuclear Medicine Market, By Applications
          1. By Diagnostic Applications
          2. By Procedural Volume Assessment
          3. By Diagnostic Procedures
          4. By Therapeutic Procedures
        3. South Korea Nuclear Medicine Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
      5. South East Asia
        1. South East Asia Nuclear Medicine Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By Therapeutic Nuclear Medicine
          3. By Brachytherapy Isotopes
        2. South East Asia Nuclear Medicine Market, By Applications
          1. By Diagnostic Applications
          2. By Procedural Volume Assessment
          3. By Diagnostic Procedures
          4. By Therapeutic Procedures
        3. South East Asia Nuclear Medicine Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Nuclear Medicine Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By Therapeutic Nuclear Medicine
          3. By Brachytherapy Isotopes
        2. Rest of Asia Pacific Nuclear Medicine Market, By Applications
          1. By Diagnostic Applications
          2. By Procedural Volume Assessment
          3. By Diagnostic Procedures
          4. By Therapeutic Procedures
        3. Rest of Asia Pacific Nuclear Medicine Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
  7. Latin America Nuclear Medicine Market - Segment Analysis
    1. Overview
    2. Latin America Nuclear Medicine Market, 2016 - 2028 (USD Million)
    3. Latin America Nuclear Medicine Market, by Type
      1. By Diagnostic Nuclear Medicine
      2. By Therapeutic Nuclear Medicine
      3. By Brachytherapy Isotopes
    4. Latin America Nuclear Medicine Market, by Applications
      1. By Diagnostic Applications
      2. By Procedural Volume Assessment
      3. By Diagnostic Procedures
      4. By Therapeutic Procedures
    5. Latin America Nuclear Medicine Market, by Procedural Volume Assessment
      1. By Diagnostic Procedures
      2. By Therapeutic Procedures
    6. Latin America Nuclear Medicine Market, by Country
      1. Brazil
        1. Brazil Nuclear Medicine Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By Therapeutic Nuclear Medicine
          3. By Brachytherapy Isotopes
        2. Brazil Nuclear Medicine Market, By Applications
          1. By Diagnostic Applications
          2. By Procedural Volume Assessment
          3. By Diagnostic Procedures
          4. By Therapeutic Procedures
        3. Brazil Nuclear Medicine Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
      2. Argentina
        1. Argentina Nuclear Medicine Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By Therapeutic Nuclear Medicine
          3. By Brachytherapy Isotopes
        2. Argentina Nuclear Medicine Market, By Applications
          1. By Diagnostic Applications
          2. By Procedural Volume Assessment
          3. By Diagnostic Procedures
          4. By Therapeutic Procedures
        3. Argentina Nuclear Medicine Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
      3. Rest of Latin America
        1. Rest of Latin America Nuclear Medicine Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By Therapeutic Nuclear Medicine
          3. By Brachytherapy Isotopes
        2. Rest of Latin America Nuclear Medicine Market, By Applications
          1. By Diagnostic Applications
          2. By Procedural Volume Assessment
          3. By Diagnostic Procedures
          4. By Therapeutic Procedures
        3. Rest of Latin America Nuclear Medicine Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
  8. Middle East & Africa Nuclear Medicine Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Nuclear Medicine Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Nuclear Medicine Market, by Type
      1. By Diagnostic Nuclear Medicine
      2. By Therapeutic Nuclear Medicine
      3. By Brachytherapy Isotopes
    4. Middle East & Africa Nuclear Medicine Market, by Applications
      1. By Diagnostic Applications
      2. By Procedural Volume Assessment
      3. By Diagnostic Procedures
      4. By Therapeutic Procedures
    5. Middle East & Africa Nuclear Medicine Market, by Procedural Volume Assessment
      1. By Diagnostic Procedures
      2. By Therapeutic Procedures
    6. Middle East & Africa Nuclear Medicine Market, by Country
      1. GCC Countries
        1. GCC Countries Nuclear Medicine Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By Therapeutic Nuclear Medicine
          3. By Brachytherapy Isotopes
        2. GCC Countries Nuclear Medicine Market, By Applications
          1. By Diagnostic Applications
          2. By Procedural Volume Assessment
          3. By Diagnostic Procedures
          4. By Therapeutic Procedures
        3. GCC Countries Nuclear Medicine Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
      2. South Africa
        1. South Africa Nuclear Medicine Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By Therapeutic Nuclear Medicine
          3. By Brachytherapy Isotopes
        2. South Africa Nuclear Medicine Market, By Applications
          1. By Diagnostic Applications
          2. By Procedural Volume Assessment
          3. By Diagnostic Procedures
          4. By Therapeutic Procedures
        3. South Africa Nuclear Medicine Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Nuclear Medicine Market, By Type
          1. By Diagnostic Nuclear Medicine
          2. By Therapeutic Nuclear Medicine
          3. By Brachytherapy Isotopes
        2. Rest of Middle East & Africa Nuclear Medicine Market, By Applications
          1. By Diagnostic Applications
          2. By Procedural Volume Assessment
          3. By Diagnostic Procedures
          4. By Therapeutic Procedures
        3. Rest of Middle East & Africa Nuclear Medicine Market, By Procedural Volume Assessment
          1. By Diagnostic Procedures
          2. By Therapeutic Procedures
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Curium
    2. Bracco Imaging S.P.A.
    3. Pharmalogic
    4. Eczacibaşi-Monrol Nuclear Products
    5. Cardinal Health
    6. NTP Radioisotopes SOC LTD. (A Subsidiary of South African Nuclear Energy Corporation)
    7. GE Healthcare
    8. Nordion Inc. (A Sotera Health Company)
    9. Advanced Accelerator Applications (AAA) (A part of Novartis)
    10. Northstar Medical Radioisotopes LLC
    11. Eckert & Ziegler
    12. Joint Stock Company Isotope (JSC Isotope)
    13. Bayer AG
    14. Siemens Healthineers
    15. Jubilant Draximage Inc. (A Subsidiary of Jubilant Pharma)
    16. Lantheus Medical Imaging Inc.
    17. Global Medical Solutions
    18. Shine Medical Technologies
    19. Isotopia Molecular Imaging Ltd.
    20. Sinotau Pharmaceutical Group
    21. Institute of Isotopes Co. Ltd.
    22. China Isotope & Radiation Corporation
    23. Yantai Dongcheng Pharmaceutical Group Co. Ltd.
    24. Cyclopharm
    25. IRE Elit
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
Vantage Market Research | 15-Sep-2022
Nuclear Medicine Market to Reach Valuation of USD 15.2 Billion by 2028 – the Rapid Technological Advancement in Nuclear Imaging Techniques, Drives the Market
FAQ
Frequently Asked Question

  • The global Nuclear Medicine valued at USD 7.88 Billion in 2022 and is expected to reach USD 20.37 Billion in 2030 growing at a CAGR of 12.60%.

  • The prominent players in the market are Curium, Bracco Imaging S.P.A., Pharmalogic, Eczacibaşi-Monrol Nuclear Products, Cardinal Health, NTP Radioisotopes SOC LTD. (A Subsidiary of South African Nuclear Energy Corporation), GE Healthcare, Nordion Inc. (A Sotera Health Company), Advanced Accelerator Applications (AAA) (A part of Novartis), Northstar Medical Radioisotopes LLC, Eckert & Ziegler, Joint Stock Company Isotope (JSC Isotope), Bayer AG, Siemens Healthineers, Jubilant Draximage Inc. (A Subsidiary of Jubilant Pharma), Lantheus Medical Imaging Inc., Global Medical Solutions, Shine Medical Technologies, Isotopia Molecular Imaging Ltd., Sinotau Pharmaceutical Group, Institute of Isotopes Co. Ltd., China Isotope & Radiation Corporation, Yantai Dongcheng Pharmaceutical Group Co. Ltd., Cyclopharm, IRE Elit.

  • The market is project to grow at a CAGR of 12.60% between 2023 and 2030.

  • The driving factors of the Nuclear Medicine include

    • Increasing incidence and prevalence of target conditions

  • North America was the leading regional segment of the Nuclear Medicine in 2022.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy